Nanobiotix Balance Sheet Health
Financial Health criteria checks 3/6
Nanobiotix has a total shareholder equity of €-1.8M and total debt of €0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are €93.9M and €95.7M respectively.
Key information
0%
Debt to equity ratio
€0
Debt
| Interest coverage ratio | n/a |
| Cash | €75.28m |
| Equity | -€1.84m |
| Total liabilities | €95.74m |
| Total assets | €93.90m |
Recent financial health updates
We're Keeping An Eye On Nanobiotix's (EPA:NANO) Cash Burn Rate
Apr 26
Is Nanobiotix (EPA:NANO) Weighed On By Its Debt Load?
May 11Nanobiotix (EPA:NANO) Has Debt But No Earnings; Should You Worry?
Dec 06Is Nanobiotix (EPA:NANO) Using Too Much Debt?
Jun 04Recent updates
We're Keeping An Eye On Nanobiotix's (EPA:NANO) Cash Burn Rate
Apr 26Is Nanobiotix (EPA:NANO) Weighed On By Its Debt Load?
May 11Nanobiotix (EPA:NANO) Has Debt But No Earnings; Should You Worry?
Dec 06Is Nanobiotix (EPA:NANO) Using Too Much Debt?
Jun 04How Should Investors React To Nanobiotix's (EPA:NANO) CEO Pay?
Dec 22
Financial Position Analysis
Short Term Liabilities: NANO has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Long Term Liabilities: NANO has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Debt to Equity History and Analysis
Debt Level: NANO is debt free.
Reducing Debt: NANO's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: NANO has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: NANO has sufficient cash runway for 2 years if free cash flow continues to reduce at historical rates of 1.4% each year.